Baldwin Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.87M Sell
1,561
-3
-0.2% -$3.06K 0.12% 88
2026
Q1
$1.44M Sell
1,564
-747
-32% -$757K 0.1% 93
2025
Q4
$2.48M Buy
2,311
+34
+1% +$32.5K 0.16% 78
2025
Q3
$1.74M Hold
2,277
0.11% 91
2025
Q2
$1.77M Hold
2,277
0.12% 84
2025
Q1
$1.88M Buy
2,277
+12
+0.5% +$9.98K 0.13% 80
2024
Q4
$1.75M Buy
2,265
+154
+7% +$128K 0.12% 86
2024
Q3
$1.87M Buy
2,111
+846
+67% +$761K 0.13% 91
2024
Q2
$1.15M Buy
1,265
+14
+1% +$11.2K 0.09% 96
2024
Q1
$973K Sell
1,251
-21
-2% -$14.9K 0.07% 109
2023
Q4
$741K Hold
1,272
0.06% 117
2023
Q3
$683K Hold
1,272
0.06% 124
2023
Q2
$597K Sell
1,272
-25
-2% -$10.5K 0.05% 141
2023
Q1
$445K Sell
1,297
-40
-3% -$13.5K 0.04% 169
2022
Q4
$489K Buy
1,337
+444
+50% +$157K 0.04% 160
2022
Q3
$289K Hold
893
0.04% 145
2022
Q2
$290K Hold
893
0.04% 151
2022
Q1
$256K Hold
893
0.03% 183
2021
Q4
$247K Buy
893
+75
+9% +$19K 0.02% 189
2021
Q3
$189K Sell
818
-132
-14% -$32.6K 0.02% 203
2021
Q2
$218K Sell
950
-43
-4% -$8.64K 0.02% 191
2021
Q1
$186K Hold
993
0.02% 188
2020
Q4
$168K Hold
993
0.02% 191
2020
Q3
$147K Hold
993
0.02% 185
2020
Q2
$163K Hold
993
0.02% 166
2020
Q1
$138K Sell
993
-407
-29% -$55.9K 0.02% 175
2019
Q4
$184K Hold
1,400
0.03% 186
2019
Q3
$157K Hold
1,400
0.02% 190
2019
Q2
$155K Hold
1,400
0.02% 214
2019
Q1
$182K Buy
+1,400
New +$170K 0.03% 207
2018
Q2
Sell
-3,432
Closed -$266K 518
2018
Q1
$266K Hold
3,432
0.04% 173
2017
Q4
$290K Hold
3,432
0.05% 168
2017
Q3
$294K Hold
3,432
0.05% 163
2017
Q2
$282K Hold
3,432
0.05% 167
2017
Q1
$289K Sell
3,432
-278
-7% -$22.3K 0.05% 162
2016
Q4
$273K Sell
3,710
-7,900
-68% -$588K 0.05% 160
2016
Q3
$932K Buy
11,610
+278
+2% +$22.3K 0.17% 78
2016
Q2
$892K Sell
11,332
-125
-1% -$9.41K 0.18% 78
2016
Q1
$825K Hold
11,457
0.15% 117
2015
Q4
$965K Sell
11,457
-2,800
-20% -$232K 0.16% 123
2015
Q3
$1.19M Hold
14,257
0.2% 105
2015
Q2
$1.19M Hold
14,257
0.18% 118
2015
Q1
$1.04M Hold
14,257
0.15% 127
2014
Q4
$984K Sell
14,257
-100
-0.7% -$6.75K 0.14% 135
2014
Q3
$931K Buy
+14,357
New +$909K 0.13% 144

Other funds holding LLY

Baldwin Wealth Partners's LLY Position: Q2 2026 in Review

Baldwin Wealth Partners reduced its Eli Lilly (LLY) stake by 0.19% in Q2 2026, selling an estimated $3.06K and leaving 1,561 shares worth $1.87M. The position accounts for 0.12% of the portfolio, ranked #88.

Baldwin Wealth Partners first reported a position in LLY in Q3 2014 and has held it in 45 quarters since. The position peaked at $2.48M in Q4 2025. 2,157 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Baldwin Wealth Partners held 1,561 shares of Eli Lilly worth $1.87M as of Q2 2026.
  • Baldwin Wealth Partners sold 3 Eli Lilly shares in Q2 2026, an estimated $3.06K.
  • Eli Lilly made up 0.12% of Baldwin Wealth Partners's portfolio in Q2 2026, its #88 holding.
  • Baldwin Wealth Partners first reported a position in Eli Lilly in Q3 2014 and has held it in 45 quarters since.
  • Baldwin Wealth Partners's Eli Lilly position peaked at $2.48M in Q4 2025.
  • 2,157 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Baldwin Wealth Partners's 13F filing for Q2 2026, filed 14 Jul 2026.